Pvmed Funding Round

12/23/2022

Venture Equity

$14,000,000

Series A

The company intends to use the funds to further develop its AI cancer treatment product portfolio and ecosystem, to accelerate the adoption of its AI-defined cancer surgery and radiotherapy workflow software and hardware products by hospitals and medical technology companies.

Private & Independent

Artificial Intelligence

Room 1312, Building B, Sun Yat-Sen University Science Park,
Guangzhou, Undisclosed
CN

PVmed, founded in May 2017, is a pioneer in medical artificial intelligence and has been leading the field of AI-enhanced auxiliary diagnosis and treatment based on medical imaging across the globe. PVmed's main business is to develop and sell auxiliary diagnosis and treatment software with IT services provided, offering solutions for multi-disease and multi-modal diagnosis. Our products are all self-developed, and many technologies are at an international or domestic leading level, with more than 50 domestic patents and 20 software copyrights. Among them, the intelligent radiotherapy system for NPC auto-contouring has reached the next level and changed the industry.